MTOR and cancer: Interestingly, in contrast to what we observed in the respective parental cell lines, we did not find a significant modulation of the AMPK and mTOR pathways in SMYD3-KO cancer cells during DDR, as assessed by changes in the expression levels of relevant phospho-activated downstream targets (Figure 1b).